Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors
NCT02040558
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
MNK-010
Sponsor
Mallinckrodt